COVID-19 and chloroquine (ACP April 2020)

Accredited CPD
Group 2

Provider: ACP
Author: Brett MacFarlane

CPD Credits: 2

Overview 

Designed to give an overview of the potential use of chloroquine and its analogues for the treatment of COVID-19

Learning Objectives

After completing this activity, pharmacists should be able to:

  1. Describe the potential use of chloroquine and its analogues for the treatment of COVID-19
  2. Outline current regulatory restrictions around the prescribing and dispensing of hydroxychloroquine


The 2016 Competency Standards addressed by this activity include: 1.2, 1.3, 3.1, 3.2, 3.5, 3.6

Accreditation number: A2004COVID19-3    Accreditation expires: 31/08/2020
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2 CPD credits) upon successful completion of the associated assessment activity.